October 18, 2019
Merck nets EU CHMP positive opinion for investigational V920 ebola vaccine
Merck has received EU CHMP positive opinion for investigational V920 ebola Zaire vaccine for protection Against ebola virus disease.
Pharmaceuticals, Biotechnology and Life Sciences
Merck has received EU CHMP positive opinion for investigational V920 ebola Zaire vaccine for protection Against ebola virus disease.